FPX News and Press, First Trust US Equity Opportunities From 08/03/22

Reborn Coffee has filed proposed terms for a $6 million IPO. The firm operates a small chain of coffee shops in California. REBN is a tiny company with high operating losses that is asking investors to pay a very high price for its shares at IPO. I'm on Hold for the REBN IPO d...

MAIA Biotechnology has filed proposed terms for its IPO. The firm is developing treatment candidates for various cancers. MAIA is preparing to enter Phase 2 trials (proof of concept) for its lead candidate. The firm has no well-known institutional investors, the IPO price is f...

Hesperos has filed to raise around $21 million in an IPO. The firm is developing an animal-free toxicology testing platform. HESP is still in development for its platform and has produced contracting and uneven financial results. I'll provide a final opinion when we learn more...

Graphex Group has filed proposed terms for an $8 million IPO. The Hong Kong-based firm produces graphene products for use in lithium-ion batteries. GRFX has produced contracting revenue, increasing operating losses and operates in an uncertain regulatory environment. I'm on Ho...

Jianzhi Education Technology Group has filed proposed terms for a $30 million IPO. The company provides online education content to businesses and consumers in China. JZ is growing revenue but the firm faces regulatory uncertainty and the IPO is excessively priced, so I'm on Hold ...

For a decade, investors chased growth stocks, but now they won't touch them; will a recession and falling rates bring them back? Growth stocks are all about the future, and the CRSP Growth Index contains nothing about valuation. Young growing companies often have negative cash flow an...

Nano Labs has filed proposed terms for a $37 million U.S. IPO. The firm designs ASIC chips for crypto mining and 'metaverse' computing environments. NA has produced revenue growth from a tiny base, but the IPO is priced for perfection, and the company is subject to highly volatile...

Earnings for the S&P 500, according to Howard Silverblatt’s work at S&P, are expected to rise 7.7% in 2022. Growth stocks were grossly overvalued going into that bear market and they took the brunt of the damage. Real estate did well last week with rates falling bac...

First Trust US Equity Opportunities ETF (FPX) - $0.1517. 30-Day SEC Yield of 0.69% as of May. 31. Payable Jun 30; for shareholders of record Jun 27; ex-div Jun 24. For further details see: First Trust US Equity Opportunities ETF declares quarterly distribution of $0.1517

Biostage has filed to raise capital via an uplisting IPO to Nasdaq. The firm is developing treatments for the various gastrointestinal system and airway conditions. BSTG is still at the preclinical stage of development, so the IPO is ultra-high-risk. For further details see:...